Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000779497 | SCV000916130 | likely pathogenic | SYNE1-Related Disorders | 2017-05-08 | criteria provided, single submitter | clinical testing | The SYNE1 c.23782C>T (p.Arg7928Ter) variant is a stop-gained variant that is predicted to cause premature truncation of the protein. The p.Arg7928Ter variant has been reported in one study and is found in a compound heterozygous state in two unrelated patients with cerebellar ataxia plus (Synofzik et al. 2016). Control data are unavailable for the variant, which is not found in the 1000 Genomes Project, the Exome Sequencing Project, Exome Aggregation Consortium or the Genome Aggregation Database. While no literature was found associating the p.Arg7928Ter variant with the autosomal dominant form of Emery-Dreifuss muscular dystrophy, it cannot be ruled out as a cause of this disease, which has a variable age of onset that ranges into adulthood. Based on the evidence and due to the potential impact of stop-gained variants, the p.Arg7928Ter variant is classified as likely pathogenic for SYNE1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |